Novartis Q4 Net Profit Surges, Operating Income Down; Sees Higher FY22 Results; Stock Dips

Shares of Novartis AG were losing more than 2 percent in the morning trading in Switzerland as well as in pre- market activity on the NYSE after the Swiss drug major reported weak operating income in its fourth quarter, hurt by increased expenses, despite higher revenues. Net profit, however, soared with hefty Roche divestment gain.

from RTT - Top Story https://ift.tt/fYaUHAh6Z
via IFTTT